BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28989158)

  • 1. [Environmental risk factors for induction of the inflammatory bowel disease].
    Peng Y; Liu X; Wang X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 42(9):1100-1104. PubMed ID: 28989158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Search for Causative Environmental Factors in Inflammatory Bowel Disease.
    Rogler G; Zeitz J; Biedermann L
    Dig Dis; 2016; 34 Suppl 1():48-55. PubMed ID: 27548430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases.
    Sobczak M; Fabisiak A; Murawska N; Wesołowska E; Wierzbicka P; Wlazłowski M; Wójcikowska M; Zatorski H; Zwolińska M; Fichna J
    Pharmacol Rep; 2014 Oct; 66(5):766-75. PubMed ID: 25149979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory Bowel Disease: Historical Perspective, Epidemiology, and Risk Factors.
    Malik TA
    Surg Clin North Am; 2015 Dec; 95(6):1105-22, v. PubMed ID: 26596917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etiology and pathogenesis of inflammatory bowel disease.
    Schmidt C; Stallmach A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease in the pediatric patient.
    Ponsky T; Hindle A; Sandler A
    Surg Clin North Am; 2007 Jun; 87(3):643-58. PubMed ID: 17560417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel disease in children--clinical, endoscopic, radiologic and histopathologic investigation.
    Seo JK; Yeon KM; Chi JG
    J Korean Med Sci; 1992 Sep; 7(3):221-35. PubMed ID: 1285921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology and pathophysiology of inflammatory bowel disease--environmental factors.
    Andus T; Gross V
    Hepatogastroenterology; 2000; 47(31):29-43. PubMed ID: 10690583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet in the pathogenesis and treatment of inflammatory bowel diseases.
    Lee D; Albenberg L; Compher C; Baldassano R; Piccoli D; Lewis JD; Wu GD
    Gastroenterology; 2015 May; 148(6):1087-106. PubMed ID: 25597840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet and nutritional factors in inflammatory bowel diseases.
    Owczarek D; Rodacki T; Domagała-Rodacka R; Cibor D; Mach T
    World J Gastroenterol; 2016 Jan; 22(3):895-905. PubMed ID: 26811635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of urinary phenolic compounds, inflammatory bowel disease and chronic diarrheal symptoms: Evidence from the National Health and Nutrition Examination Survey.
    de Silva PS; Yang X; Korzenik JR; Goldman RH; Arheart KL; Caban-Martinez AJ
    Environ Pollut; 2017 Oct; 229():621-626. PubMed ID: 28689150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian rhythm abnormalities - Association with the course of inflammatory bowel disease.
    Sobolewska-Włodarczyk A; Włodarczyk M; Szemraj J; Stec-Michalska K; Fichna J; Wiśniewska-Jarosińska M
    Pharmacol Rep; 2016 Aug; 68(4):847-51. PubMed ID: 27166084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory Diseases of the Gut.
    Rohr M; Narasimhulu CA; Sharma D; Doomra M; Riad A; Naser S; Parthasarathy S
    J Med Food; 2018 Feb; 21(2):113-126. PubMed ID: 29389238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking, physical activity, nutrition and lifestyle: environmental factors and their impact on IBD.
    Cosnes J
    Dig Dis; 2010; 28(3):411-7. PubMed ID: 20926865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of animal models for the pathogenesis and treatment of inflammatory bowel disease.
    Dieleman LA; Peña AS; Meuwissen SG; van Rees EP
    Scand J Gastroenterol Suppl; 1997; 223():99-104. PubMed ID: 9200314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The cytokines in inflammatory bowel disease].
    Polińska B; Matowicka-Karna J; Kemona H
    Postepy Hig Med Dosw (Online); 2009 Aug; 63():389-94. PubMed ID: 19724079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environment and the inflammatory bowel diseases.
    Frolkis A; Dieleman LA; Barkema HW; Panaccione R; Ghosh S; Fedorak RN; Madsen K; Kaplan GG;
    Can J Gastroenterol; 2013 Mar; 27(3):e18-24. PubMed ID: 23516681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association.
    Principi M; Cassano N; Contaldo A; Iannone A; Losurdo G; Barone M; Mastrolonardo M; Vena GA; Ierardi E; Di Leo A
    World J Gastroenterol; 2016 May; 22(20):4802-11. PubMed ID: 27239107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.